Intravital Förster resonance energy transfer imaging reveals elevated [Ca2+]i and enhanced sympathetic tone in femoral arteries of angiotensin II-infused hypertensive biosensor mice

Journal of Physiology

Volumn 591, Issue 21, 2013, Pages 5321-5336

  Wang, Youhua ^a   Chen, Ling ^a   Wier, W Gil ^a   Zhang, Jin ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN RECEPTOR; ARGIPRESSIN; CALCIUM ION; CALMODULIN; HEXAMETHONIUM; LOSARTAN; PHENYLEPHRINE; PRAZOSIN; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BIOSENSOR; BLOOD VESSEL TONE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMORAL ARTERY; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FORSTER RESONANCE ENERGY TRANSFER IMAGING; HYPERTENSION; IMAGE ANALYSIS; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; MUSCLE CONTRACTION; MUSCLE SYMPATHETIC NERVE ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; SMOOTH MUSCLE; SYMPATHETIC TONE; ADRENERGIC SYSTEM; ANIMAL; CALCIUM SIGNALING; CHEMICALLY INDUCED; DRUG EFFECTS; GENETIC PROCEDURES; GENETICS; INNERVATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOSENSING TECHNIQUES; CALCIUM; CALCIUM SIGNALING; CALMODULIN; FEMORAL ARTERY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEXAMETHONIUM; HYPERTENSION; INFUSIONS, INTRAVENOUS; LOSARTAN; MICE; MUSCLE, SMOOTH, VASCULAR; PRAZOSIN; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION;

EID: 84886802416     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.257808     Document Type: Article

References (46)

1. Anning PB, Coles B, Bermudez-Fajardo A, Martin PE, Levison BS, Hazen SL, Funk CD, Kühn H & O'Donnell VB (2005). Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice. Am J Pathol 166, 653-662.
2. Bagher P & Segal SS (2011). The mouse cremaster muscle preparation for intravital imaging of the microcirculation. J Vis Exp 52: DOI: 10.3791/2011.2874.
3. Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, Eisner GM, Grandy DK, Cary RM, Soares-da-Silva P & Jose PA (2006). Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension 47, 288-295.
4. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J & Wier WG (2012). How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension Am J Physiol Heart Circ Physiol 302, H1031-H1049.
5. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z & Chiu J (2004). Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287, H695-H703.
6. Collister JP & Osborn JW (2005). Role of a responsive sympathetic nervous system in the chronic hypotensive effects of losartan in normal rats. J Cardiovasc Pharmacol 46, 147-154.
7. Den Ouden DT & Meinders AE (2005). Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review. Neth J Med 63, 4-13.
8. Ding L, Chapman A, Boyd R & Wang HD (2007). ERK activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 292, H2997-H3005.
9. Esler M, Lambert E & Schlaich M (2010). Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 109, 1996-1998.
10. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA et al. (2010). Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106, 373-382.
11. Gabor A & Leenen FH (2012). Central neuromodulatory pathways regulating sympathetic activity in hypertension. J Appl Physiol 113, 1294-1303.
12. 2+/calmodulin binding and activation of myosin light chain kinase in cells. FEBS Lett 557, 121-124.
13. Gonzalez-Villalobos RA, Satou R, Seth DM, Semprun-Prieto LC, Katsurada A, Kobori H & Navar LG (2009). Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension 53, 351-355.
14. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C & Harrison DG (2007). Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204, 2449-2460.
15. Hercule HC, Tank J, Plehm R, Wellner M, da Costa Goncalves AC, Gollasch M, Diedrich A, Jordan J, Luft FC & Gross V (2007). Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice. Exp Physiol 92, 1014-1022.
16. Hilgers RH, Todd J Jr & Webb RC (2007). Increased PDZ-RhoGEF/RhoA/Rho kinase signalling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens 25, 1687-1697.
17. Huang BS, Ahmadi S, Ahmad M, White RA & Leenen FH (2010). Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-'ouabain' pathway. Am J Physiol Heart Circ Physiol 299, H422-H430.
18. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA & Fishman MC (1995). Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242.
19. Isotani E, Zhi G, Lau KS, Huang J, Mizuno Y, Persechini A, Geguchadze R, Kamm KE & Stull JT (2004). Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. Proc Natl Acad Sci USA 101, 6279-6284.
20. Kharade SV, Sonkusare SK, Srivastava AK, Thakali KM, Fletcher TW, Rhee SW & Rusch NJ (2013). The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice. Hypertension 61, 137-142.
21. Kim S & Iwao H (2000). Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52, 11-34.
22. King AJ, Novotny M, Swain GM & Fink GD (2008). Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol 294, R1262-R1267.
23. Kirabo A, Kearns PN, Jarajapu YP, Sasser JM, Oh SP, Grant MB, Kasahara H, Cardounel AJ, Baylis C, Wagner KU & Sayeski PP (2011). Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res 91, 171-179.
24. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508, 199-209.
25. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS & Mulvany MJ (1993). Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 22, 523-526.
26. Kuroki MT, Guzman PA, Fink GD & Osborn JW (2012). Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension. Am J Physiol Heart Circ Physiol 302, H763-H769.
27. 2+ signalling, vasoconstriction, and myogenic reactivity in Milan hypertensive rats. Am J Physiol Heart Circ Physiol 302, H611-H620.
28. Lob HE, Schultz D, Marvar PJ, Davisson RL & Harrison DG (2013). Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension 61, 382-387.
29. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ & Harrison DG (2010). Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107, 263-270.
30. Martinez-Lemus LA, Hill MA & Meininger GA (2009). The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure. Physiology 24, 45-57.
31. 2+ signalling in murine cremaster muscle arterioles in vivo. Microcirculation 20, 269-277.
32. Mulvany MJ (2011). Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol 110, 49-55.
33. Navar LG (2010). Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension. J Appl Physiol 109, 1998-2000.
34. Porteri E, Rizzoni D, Mulvany MJ, De Ciuceis C, Sleiman I, Boari GE, Castellano M & Muiesan ML (2003). Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. J Hypertens 21, 2345-2352.
35. Seagard JL, Hopp FA, Bosnjak ZJ, Osborn JL & Kampine J (1984). Sympathetic efferent nerve activity in conscious and isoflurane-anaesthetized dogs. Anesthesiology 61, 266-270.
36. Sparks MA, Parsons KK, Stegbauer J, Gurley SB, Vivekanandan-Giri A, Fortner CN, Snouwaert J, Raasch EW, Griffiths RC, Haystead TA, Le TH, Pennathur S, Koller B & Coffman TM (2011). Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension 57, 577-585.
37. Sudano I, Roas S & Noll G (2011). Vascular abnormalities in essential hypertension. Curr Pharm Des 17, 3039-3044.
38. Touyz RM (2005). Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 14, 125-131.
39. 2+, FRET fluorescence and force in intact mouse small arteries. J Physiol 586, 2437-2443.
40. Xu L & Brooks VL (1996). Ang II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats. Am J Physiol Heart Circ Physiol 271, H2591-H2598.
41. Yoshimoto M, Miki K, Fink GD, King A & Osborn JW (2010). Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension 55, 644-651.
42. Young CN, Cao X, Guruju MR, Pierce JP, Morgan DA, Wang G, Iadecola C, Mark AL & Davisson RL (2012). ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. J Clin Invest 122, 3960-3964.
43. 1D-adrenoceptor subtypes. PLoS One 8, e65969.
44. i and MLCK activation in FRET-based biosensor mice. Am J Physiol Heart Circ Physiol 299, H946-H956.
45. Zhou MS, Jaimes EA & Raij L (2005). Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J Hypertens 23, 1737-1743.
46. Zimmerman MC, Lazartigues E, Sharma RV & Davisson RL (2004). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95, 210-216.